Direkt zum Inhalt
Merck

Initial catabolic steps of isoleucine, the R-pathway and the origin of alloisoleucine.

Journal of chromatography. B, Biomedical sciences and applications (2001-08-03)
O A Mamer
ZUSAMMENFASSUNG

The initial catabolic steps of isoleucine by mammals has been misunderstood and misapprehended in the scientific literature for many years. The suggestion that the interconversion of isoleucine and alloisoleucine occurs through the keto-enol racemization of their respective transaminated alpha-keto acids was first tentatively advanced by Alton Meister in the early 1950s, and accepted without hard confirming evidence by many authors. It will be shown in this brief review that isoleucine is converted to alloisoleucine with conservation of a 15N label denying the intermediacy of the alpha-keto acids, and that alloisoleucine arises as an unavoidable consequence of isoleucine transamination.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
L-Isoleucin, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-Isoleucin, reagent grade, ≥98% (HPLC)
SAFC
L-Isoleucin
Sigma-Aldrich
L-Isoleucin, BioUltra, ≥99.5% (NT)
Supelco
L-Isoleucin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Isoleucin, 99%, FCC, FG
Supelco
L-Isoleucin, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Isoleucin, European Pharmacopoeia (EP) Reference Standard